Lv5
988 积分 2025-12-11 加入
CpG-Containing Oligodeoxynucleotides Act through TLR9 to Enhance the NK Cell Cytokine Response to Antibody-Coated Tumor Cells 1
8小时前
已完结
Local delivery, lasting impact: Intraperitoneal administration of natural killer cell engagers outperform subcutaneous dosing in a xenogeneic model of ovarian cancer
21天前
已完结
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
1个月前
已完结
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
1个月前
已完结
Bi-specific and Tri-specific NK Cell Engagers: The New Avenue of Targeted NK Cell Immunotherapy
3个月前
已完结
Evaluation of a human peripheral blood NK humanized hIL-15 mouse model lacking murine Fc gamma receptors
3个月前
已关闭
Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial
4个月前
已完结
Innate Cell Engager (ICE®) AFM13 Combined with Preactivated and Expanded (P+E) Cord Blood (CB)-Derived Natural Killer (NK) Cells for Patients with Refractory CD30-Positive Lymphomas: Final Results
4个月前
已关闭
From innate immunity to precision cancer therapy: the clinical advancement of NK cell therapy
4个月前
已完结
Evaluation of serum-free media formulations in feeder cell–stimulated expansion of natural killer cells
5个月前
已完结
皖公网安备34019202002308
